Welcure Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/12/2025 ,inter alia, to consider and approve To augment ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Welcure Drugs & Pharmaceuticals has informed BSE that its Board Meeting, originally scheduled for November 27, 2025, has been postponed to December 01, 2025 due to unavailability of directors. The rescheduled meeting will, among other things, consider and approve augmenting the company's financial resources through potential fund-raising. Possible routes include equity shares, convertible instruments, other securities via preferential allotment, rights issue, QIPs, ADRs, GDRs, FCCBs or any combination, in one or more tranches. No pricing, size, or specific instrument has been disclosed at this stage.
No immediate impact on shareholders — this is purely a logistical postponement of a board meeting. However, investors should watch the December 1 meeting closely, as approval of a fund-raising plan could lead to dilution depending on the route and size finally chosen.